Past Conventional Strategies: Enhancing Sturdiness in NETs Care with Mixed Therapy | Targeted Oncology
In an interview with Targeted Oncology on the 2025 North American Neuroendocrine Tumor Society (NANETS) Symposium, Michael Soulen, MD, mentioned…
Past Conventional Strategies: Enhancing Sturdiness in NETs Care with Mixed Therapy | Targeted Oncology Read More